Investing.com - Bicycle Therapeutics (NASDAQ:BCYC) reported on Thursday first quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Bicycle Therapeutics announced earnings per share of $-0.73 on revenue of $1.8M. Analysts polled by Investing.com anticipated EPS of $-0.6814 on revenue of $1.95M.
Bicycle Therapeutics shares are up 2% from the beginning of the year, still down 5.89% from its 52 week high of $33.11 set on April 28. They are under-performing the S&P 500 which is up 10.96% from the start of the year.
Bicycle Therapeutics follows other major Healthcare sector earnings this month
Bicycle Therapeutics's report follows an earnings beat by J&J on April 20, who reported EPS of $2.59 on revenue of $22.32B, compared to forecasts EPS of $2.34 on revenue of $21.98B.
Pfizer had beat expectations on Tuesday with first quarter EPS of $0.93 on revenue of $14.58B, compared to forecast for EPS of $0.7773 on revenue of $13.67B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar